Precursors of Skin Carcinoma
Author:
Ranawaka Ranthilaka R.
Publisher
Springer Singapore
Reference32 articles.
1. Akel R, Fuller C (2018) Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol 178(4):823–824. https://doi.org/10.1111/bjd.16445
2. Arakeri G, Patil SG, Aljabab AS et al (2017) Oral submucous fibrosis: An update on pathophysiology of malignant transformation. J Oral Pathol Med 46(6):413–417. https://doi.org/10.1111/jop.12582. Epub 2017 May 6
3. Attili VR, Attili SK (2008) Vitiligoid lichen sclerosus: a reappraisal. Indian J Dermatol Venereol Leprol 74(2):118–121
4. Bari S, Metgud R, Vyas Z, Tak A (2017) An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis. J Cancer Res Ther 13(3):399–405. https://doi.org/10.4103/0973-1482.179524
5. Bazarsad S, Zhang X, Kim KY et al (2017) Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. J Oral Pathol Med 46(6):431–438. https://doi.org/10.1111/jop.12483. Epub 2016 Aug 6